Enlivex Therapeutics Ltd. buy melinda
Start price
26.09.17
/
50%
€14.65
Target price
28.09.17
€18.04
Performance (%)
13.71%
End price
28.09.17
€16.66
Summary
This prediction ended on 28.09.17 with a price of €16.66. The BUY prediction by melinda finished with a performance of 13.71%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Enlivex Therapeutics Ltd. | -17.123% | -17.123% | -23.899% | -75.205% |
| iShares Core DAX® | -2.195% | 0.670% | 0.546% | 51.111% |
| iShares Nasdaq 100 | -2.629% | 2.992% | 34.108% | 91.988% |
| iShares Nikkei 225® | -2.021% | 3.141% | 53.424% | 65.852% |
| iShares S&P 500 | -1.670% | 2.405% | 23.220% | 66.636% |
Comments by melinda for this prediction
In the thread Enlivex Therapeutics Ltd. diskutieren
Phase LE2 / 02/2017
zu folgen
(Vom Mitglied beendet)
Stopped prediction by melinda for Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€21.20
25.10.17
25.10.17
€22.40
20.12.17
20.12.17
6.79%
20.12.17
20.12.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€19.12
25.10.17
25.10.17
€20.20
20.12.17
20.12.17
6.79%
20.12.17
20.12.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€16.24
26.09.17
26.09.17
€20.00
28.09.17
28.09.17
13.71%
28.09.17
28.09.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€47.63
27.01.17
27.01.17
€72.16
27.07.17
27.07.17
-53.77%
27.07.17
27.07.17
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€185.81
14.10.15
14.10.15
€234.52
14.04.16
14.04.16
-54.95%
14.04.16
14.04.16